Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v1-EN
Language English English
Date Updated 2018-01-23 2017-03-17
Drug Identification Number 02312263 02312263
Brand name CESAMET CESAMET
Common or Proper name CESAMET CESAMET
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients NABILONE NABILONE
Strength(s) 0.25MG 0.25MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 50 50
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2018-02-15 2017-06-15
Actual start date
Estimated end date 2018-05-15 2018-02-15
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments